AbstractThe aim of this prospective, uncontrolled clinical study was to evaluate the tolerability and the efficacy of levetiracetam as add-on treatment in 78 adults and 44 children with intractable epilepsy. The patients’ seizure frequency in the 8 weeks baseline period was compared to their seizure frequency after a mean follow-up of 8 months of treatment.A greater than 50% reduction in seizure frequency was achieved in 31 adults (40%) and 9 children (20%), of whom 7 adults (9%) and 3 children (7%) became seizure free. Most often levetiracetam was well tolerated, somnolence being the most frequently reported side effect (18% in adults and 7% in children). However, in 14 adults (18%) and 19 children (43%) levetiracetam was associated with a...
AbstractBackground: The novel antiepileptic drug (AED) levetiracetam (LEV, Keppra®) is indicated as ...
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and sa...
AbstractBackgroundThere are limited data on the use of the antiepileptic drug (AED) levetiracetam fo...
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and s...
SummaryPurpose:To evaluate the efficacy and tolerability of Levetiracetam (LEV) in a large pediatric...
SummaryWe examined the efficacy, optimum dosage and adverse effects of levetiracetam in two prospect...
AbstractLevetiracetam is highly effective as add-on treatment in refractory partial-onset seizures b...
AbstractPurposeThe goals of this study are to evaluate the efficacy and tolerability of levetiraceta...
SummaryThe aim of this multicentric, retrospective, and uncontrolled study was to evaluate the effic...
AbstractThis prospective observational study explored the efficacy and tolerability of levetiracetam...
To evaluate the efficacy and safety of levetiracetam (LEV) in refractory crypto/symptomatic, partial...
AbstractProblem: Levetiracetam (LEV) is a new antiepileptic drug shown to be effective for the treat...
AbstractThis prospective open-label study used flexible dosing schedules of levetiracetam (LEV) in p...
AbstractPurposeTo investigate the efficacy and safety of levetiracetam in adults with intellectual d...
Background: The Common neurological disorder in pediatric population is epilepsy. Despite having man...
AbstractBackground: The novel antiepileptic drug (AED) levetiracetam (LEV, Keppra®) is indicated as ...
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and sa...
AbstractBackgroundThere are limited data on the use of the antiepileptic drug (AED) levetiracetam fo...
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and s...
SummaryPurpose:To evaluate the efficacy and tolerability of Levetiracetam (LEV) in a large pediatric...
SummaryWe examined the efficacy, optimum dosage and adverse effects of levetiracetam in two prospect...
AbstractLevetiracetam is highly effective as add-on treatment in refractory partial-onset seizures b...
AbstractPurposeThe goals of this study are to evaluate the efficacy and tolerability of levetiraceta...
SummaryThe aim of this multicentric, retrospective, and uncontrolled study was to evaluate the effic...
AbstractThis prospective observational study explored the efficacy and tolerability of levetiracetam...
To evaluate the efficacy and safety of levetiracetam (LEV) in refractory crypto/symptomatic, partial...
AbstractProblem: Levetiracetam (LEV) is a new antiepileptic drug shown to be effective for the treat...
AbstractThis prospective open-label study used flexible dosing schedules of levetiracetam (LEV) in p...
AbstractPurposeTo investigate the efficacy and safety of levetiracetam in adults with intellectual d...
Background: The Common neurological disorder in pediatric population is epilepsy. Despite having man...
AbstractBackground: The novel antiepileptic drug (AED) levetiracetam (LEV, Keppra®) is indicated as ...
The aim of this multicentric, prospective and uncontrolled study was to evaluate the efficacy and sa...
AbstractBackgroundThere are limited data on the use of the antiepileptic drug (AED) levetiracetam fo...